Skip to main content

BioVenture — Portfolio, Page 7

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

279
Companies
$2.1B
Total invested
$23.9M
Avg. check
25
Industries
Biotechnology 13Medical 12Health Care 10Biopharma 5Pharmaceutical 5Therapeutics 5+19 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 145–168 of 279
Junhemeng Biopharmaceutical
May 2025

Junhemeng is a research and development company of recombinant protein drugs.

Biopharma · Hangzhou$1.4M Series Unknown
Hillhurst Biopharmaceuticals
May 2025

Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.

Advanced Materials · San Diego$6.3M Grant
Kossel Medical
April 2025

Kossel Medical is a medical device R&D, manufacturer of vascular interventional devices to provide clinical system solutions.

Health Care · Suzhou$13.7M Series B
Shanhai Innovation
April 2025

Shanhai Innovation is a medical science company that provides supramolecular science and technology research and development solutions.

Biotechnology · Shenzhen$13.7M Series C
Novlead Biotech
April 2025

Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.

Biotechnology · NanjingSeries C
Apeximmune Therapeutics
March 2025

Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.

Biotechnology · Burlingame$21.3M Series A
Cellbri
March 2025

Cellbri is a manufacturing company that produces and sells automated CGT industrial instruments for cell processing programs.

Machinery Manufacturing · ShanzhenSeries B
Myrobalan Therapeutics
March 2025

Myrobalan Therapeutics is a biotechnology company developing oral neurorestorative therapies for individuals with CNS diseases.

Biotechnology · Medford$850K Grant
MyoGene Life Sciences
January 2025

MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its repair material products for bone repair.

Advanced Materials · ShenzhenSeries A
AnaCardio
January 2025

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Biopharma · Solna$18.4M Series A
Alebund Pharmaceuticals
January 2025

Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.

Biotechnology · Shanghai$75.1M Series C
Francis Medical
January 2025

Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.

Medical · Maple Grove$80.0M Series C
Reforgene Medicine
December 2024

Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop drugs intended to cure genetic diseases.

Biotechnology · GuangzhouSeries Unknown
Ruixun Biotech
December 2024

Ruixun Biotech is a healthcare company that provides biotechnology.

Biotechnology · SuzhouSeries C
Farber Xintian
December 2024

Farber Xintian CRO company engaged in clinical services of radionuclide drugs.

Medical$13.8M Series A
Valora Therapeutics
November 2024

Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .

Biopharma · La Jolla$30.0M Seed
MacroLux
October 2024

MacroLux operates as a medical technology company focusing on endoscopic interventional business.

Health Care · Shenzhen$14.0M Series B
IntoCare
October 2024

IntoCare is a high-tech company specializing in surgical products.

Health Care · Suzhou$10.0M Series D
Pro-Heal Pharmaceuticals
June 2024

Pro-Heal Pharmaceuticals is a biotechnology based pharmaceutical manufacturing company.

Biopharma · Suzhou$5.5M Corporate Round
āshibio
June 2024

āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

Biotechnology · Brisbane$40.0M Series A
Simergent
May 2024

Simergent is developing an affordable home dialysis devices to address unmet patient needs and improve value-based care.

Emerging Markets · Chicago$7.8M Series Unknown
Youzhong New Material Technology
April 2024

Youzhong New Materials is a micro-nano device R&D company that designs, develops, and manufactures micro-nano devices .

Manufacturing · Zhoushan$13.8M Series A
Bask Health
April 2024

SaaS, Healthcare, E-commerce

Electronic Health Record (EHR) · New York$760K Seed
Jushu Biotech
April 2024

Jushu Biotech is a medical engineering company that focuses on the research and development of synthetic biosensing technology.

Biopharma · ChangpingSeries A

Where BioVenture invests

Biotechnology13
Medical12
Health Care10
Biopharma5
Pharmaceutical5
Therapeutics5

About BioVenture's portfolio

How many companies has BioVenture invested in?▸

BioVenture has invested in 279 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does BioVenture invest in?▸

BioVenture's top investment sectors include Biotechnology, Medical, Health Care, Biopharma, Pharmaceutical. The firm invests across 25 different industry categories.

What is BioVenture's largest investment?▸

Among tracked funding rounds, Francis Medical received $80.0M in a Series C round. BioVenture's total known invested capital is $2.1B.

What is the average investment size for BioVenture?▸

BioVenture's average investment size is $23.9M across its portfolio of 279 companies.

What are BioVenture's most recent investments?▸

Recent BioVenture portfolio additions include Junhemeng Biopharmaceutical, Hillhurst Biopharmaceuticals, Kossel Medical, Shanhai Innovation, Novlead Biotech. These companies were founded in 2020 or later.

Reach the founders behind these 279 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →